China Concludes First-Ever Securities Class Action With a Slap-on-the-Wrist Order
Nov 22, 2021
| By Jessica Seah
In China's first-ever securities class action, Kangmei Pharmaceuticals has been ordered to pay $385 million as compensation—just enough for 50,000 investors to recoup their losses.
X
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
(This article was first published on Law.com International.)
This premium content is reserved for China Law & Practice Subscribers.
A Premium Subscription Provides:
A database of over 3,000 essential documents including key PRC legislation translated into English
A choice of newsletters to alert you to changes affecting your business including sector specific updates
Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment